Diabetes Mellitus, Type 2: all 9,590 studies
Page 75 of 96. Open to participants first (1,331), then studies with results posted, then the rest; newest registration first within each.
- Functional MRI Biomarkers of Cognitive Decrements in DiabetesCompletedNCT01705210
- Evaluation of Block Duration in Type 2 Diabetes PatientsCompletedNCT01704612Phase 4
- Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen™ in Subjects With Type 2 DiabetesCompletedNCT01704378Phase 4
- Efficacy and Safety Comparative Study of Sitagliptin,Vildagliptin and SaxagliptinStatus unknownNCT01703637Not applicable
- Diabetes in India Nutrition Guidelines Study (DINGS)CompletedNCT01703611Not applicable
- Almased Multi-Center Diabetes Intervention TrialCompletedNCT01702012Not applicable
- Barriers to Physical Activity in People With Type 2 DiabetesCompletedNCT01701570Not applicable
- Practice Based Nutrition Intervention-2CompletedNCT01700868Not applicable
- Physical and Chemical Study of Atherosclerosis MechanismsCompletedNCT01700075Phase 4
- Efficacy and Safety of the Fixed Dose Combination of Glimepiride+Metformin in Type 2 Diabetic Patients Inadequately ControlledCompletedNCT01699932Phase 3
- Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes MellitusCompletedNCT01699737Phase 2
- Acute Dose Response of Korean White Ginseng in Metabolic Syndrome or Type 2 DiabetesCompletedNCT01699074Phase 1
- Efficacy of Repaglinide in Subjects With Type 2 DiabetesCompletedNCT01698931Phase 4
- Glycemic Control of Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT01697631Phase 4
- Pharmacokinetics, Pharmacodynamics and Safety of Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT01697618Phase 2
- An International Survey on Hypoglycaemia Among Insulin-treated Patients With DiabetesCompletedNCT01696266
- A Pilot Intervention Study of Health Coaching to Promote Diabetes Self-Care in the CommunityCompletedNCT01695278Phase 3
- OPtimal Type 2 dIabetes Management Including Benchmarking and Standard Treatment in CEEMEACompletedNCT01694758
- Tissue Distribution of F18-FDG Labelled Autologous Bone Marrow Derived Stem Cells in Patients With Type 2 DMStatus unknownNCT01694173Phase 2/3
- Be Healthy in Pregnancy (B-HIP): A Trial to Study Nutrition and Exercise Approaches for Healthy PregnancyCompletedNCT01693510Not applicable
- A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Sulfonylurea Alone or Sulfonylurea Plus Metformin TherapyCompletedNCT01691989Phase 3
- A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin AloneCompletedNCT01691846Phase 3
- A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic TherapyCompletedNCT01691755Phase 3
- Investigation on Safety, Tolerability, and Pharmacokinetics of Single Doses of NNC0113-0987 in Healthy Male SubjectsCompletedNCT01690169Phase 1
- Comparison of a New Formulation of Insulin Glargine With Lantus® Both in Combination With Oral Antihyperglycemic Drug(s) in Japanese Patients With Type 2 Diabetes MellitusCompletedNCT01689142Phase 3
- Vasodilatory and Metabolic Effects of Glucagon-like Peptide-1 in Periphery Circulation in Patients With and Without Type 2 Diabetes MellitusCompletedNCT01689051Not applicable
- Telemedicine as a Means to Achieving Good Diabetes Control Among Patients With Type 2 DiabetesCompletedNCT01688778Not applicable
- Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic PatientsCompletedNCT01687582Not applicable
- Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long-acting GLP-1 Analogue in Healthy Male Subjects and Male Subjects With Type 2 DiabetesCompletedNCT01686945Phase 1
- Safety Study of Stem Cells Treatment in Diabetic Foot UlcersStatus unknownNCT01686139Phase 1
- VERifynow in DIabetes Non-responsiveness: a Study on Switching From Clopidogrel to PrasugrelCompletedNCT01684813Phase 4
- Enhancing Informal Caregiving to Support Diabetes Self-ManagementCompletedNCT01684709Not applicable
- Effect of Genetic Variants in MATE1 and OCT3 on the Pharmacodynamics of Metformin in African AmericansCompletedNCT01681693Phase 1
- A Cohort Study of Incretin-based Therapy Combined With Insulin in Type 2 Diabetic Patients for 5 YearsStatus unknownNCT01681550Not applicable
- A Study to Evaluate the Effect of Aleglitazar on Cardiac Energetics and Function in Patients With Type 2 Diabetes Mellitus and no History of Coronary Artery DiseaseCompletedNCT01680978Phase 2
- Metabolic Activation With Almased for Type 2 Diabetes PatientsCompletedNCT01680926Early Phase 1
- Regulation of Tissue Lipolysis by Insulin in Type 2 DiabetesCompletedNCT01680133
- Effect of Anti-diabetic Drugs on Bone Metabolism and Glycemic VariabilityCompletedNCT01679899Phase 4
- Effects of Resveratrol in Patients With Type 2 DiabetesCompletedNCT01677611Phase 1
- Autologous Bone Marrow Mononuclear Cell Transplantation in Treating Type 2 Diabetes MellitusCompletedNCT01677013Phase 1/2
- A Clinical Trial to Study the Efficacy, Safety, Tolerability and Pharmacokinetics of P2202 in Patients of Type 2 DiabetesTerminatedNCT01674348Phase 2
- A Study to Evaluate Long-term Safety and Efficacy of ASP1941 in Diabetes PatientsCompletedNCT01672762Phase 3
- Automated SMS-Based Appointment Validation ToolStatus unknownNCT01671189Early Phase 1
- Point of Service Diabetes Screening EvaluationCompletedNCT01669616
- A Primary Care, EHR- Based Strategy to Promote Safe and Appropriate Drug UseCompletedNCT01669473Not applicable
- Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood PressureCompletedNCT01667614Phase 2
- Effect of Bile Acids on GLP-1 SecretionCompletedNCT01666223Not applicable
- A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 DiabetesCompletedNCT01665352Phase 2
- Effects of Liraglutide on Kidney Function in Type 2 Diabetic PatientsCompletedNCT01664676Phase 4
- Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes MellitusCompletedNCT01663220
- Characterization of the Variability Of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With PrediabetesCompletedNCT01663207
- Study of Comparing the Different Effect of DPP-4 Inhibitors and Sulfonylurea by Using "Biphase-Hyperglycemic Clamp"Status unknownNCT01660386Phase 4
- Diabetes Outcomes and Nurse Case Manager StudyCompletedNCT01659294Not applicable
- Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DMCompletedNCT01658501Phase 2
- Tertiary Prevention in Type II Diabetes Mellitus in Canary Islands StudyCompletedNCT01657227Not applicable
- Vitamin D, Cardiovascular Disease, and African AmericansCompletedNCT01655810Not applicable
- A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Effects of Bardoxolone Methyl on Body Composition in Patients With Stage 4 Chronic Kidney Disease and Type 2 Diabetes MellitusWithdrawnNCT01655186Phase 2
- Multi-Modal Intervention In Frail And Prefrail Older People With Type 2 DiabetesCompletedNCT01654341Not applicable
- Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II DiabeticsCompletedNCT01654120Phase 4
- Micro-Clinic Obesity and Metabolic Risk Prevention ProgramCompletedNCT01651065Not applicable
- Safety and Efficacy of Biphasic Insulin Aspart 50 in Subjects With Type 2 DiabetesCompletedNCT01650129Phase 3
- Safety and Efficacy of Insulin Aspart in Type 2 DiabetesCompletedNCT01649570Phase 4
- Safety and Efficacy of Vildagliptin Versus NPH Insulin add-on to Glimepiride in Type 2 Diabetes Mellitus Patients.CompletedNCT01649466Phase 4
- The Use of a Computer Program to Help Primary Care Providers Treat Patients With Type 2 DiabetesCompletedNCT01648244Not applicable
- Mechanistic Study of ISIS ISIS-APOCIIIRX in Type 2 DiabetesTerminatedNCT01647308Phase 2
- The Impact of Reformulated Foods on Cardiovascular Risk FactorsCompletedNCT01645995Not applicable
- Efficacy and Safety of DLBS3233 in Subjects With New Onset of Type 2 Diabetes MellitusCompletedNCT01645332Phase 3
- A Study Evaluating the Effects of a High Viscosity Non-starch Polysaccharide (PolyGlycopleX® - PGX®) on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II DiabeticsTerminatedNCT01644201Phase 3
- Treatment With Sitagliptin in Non-obese Japanese Patients With Type 2 Diabetes MellitusStatus unknownNCT01642108Not applicable
- Resveratrol and Type 2 DiabetesStatus unknownNCT01638780Not applicable
- Resistance Training in Diabetic Elder PatientsCompletedNCT01638351Not applicable
- GLP-1 and Non-exercise Activity Thermogenesis in RHZTerminatedNCT01638260Phase 4
- Health Effects of Recreational Soccer in Type 2 Diabetic MenCompletedNCT01636349Not applicable
- Understanding and Appraising the New Medicine Service in EnglandCompletedNCT01635361Not applicable
- Evaluation of SCOUT DS Device in the Diagnosis of DiabetesStatus unknownNCT01634997
- Along-term Study of OPC-262 in Patients With Type 2 DiabetesCompletedNCT01634282Phase 3
- Assessment of the Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Insufficiently Controlled With Basal Insulin +/- MetforminCompletedNCT01632163Phase 3
- Efficacy and Safety of Insuman Basal/Comb/Rapid in Patients With Type 2 DiabetesCompletedNCT01630369Phase 4
- Study of Liraglutide in Individuals With Type 2 Diabetes Using InsulinTerminatedNCT01628445Phase 3
- French Observational Survey to Assess Hypoglycaemia in Insulin-treated Diabetic PatientsCompletedNCT01628341
- Measurement of Eye Blood Flow and Renal Function in Healthy and Diabetic PatientsStatus unknownNCT01626469Phase 1/2
- The Efficacy and Treatment Adherence With an Integrated Program on HbA1c Scores in Patients With Type 2 DiabetesCompletedNCT01626053Not applicable
- Comparison of Hypoglycaemic Regimens During Ramadan Fasting in Type 2 DiabetesCompletedNCT01624116Not applicable
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Healthy Japanese VolunteersCompletedNCT01620463Phase 1
- Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and 50 in Subjects With Type 2 DiabetesCompletedNCT01620424Phase 1
- Metabolic Control Before and After Supplementation With Lactobacillus Reuteri DSM 17938 in Type 2 Diabetes PatientsCompletedNCT01620125Early Phase 1
- Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763CompletedNCT01619332Phase 1/2
- Rapid Effects Linagliptin on Monocyte Polarization and Endothelial Progenitor Cells in Type 2 DiabetesCompletedNCT01617824Phase 4
- Safety and Tolerability of Liraglutide in Japanese Subjects With Type 2 DiabetesCompletedNCT01615978Phase 1
- A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-5823 in Overweight or Obese Participants Who Are Healthy or Have Type 2 Diabetes Mellitus (MK-5823-002)TerminatedNCT01614782Phase 1
- Examining The Role of CGM in T2DMCompletedNCT01614262Not applicable
- Diabetes Treatment With Glucobay in Combination With SulfonylureaCompletedNCT01613105
- Diabetes Treatment With Glucobay in Combination With MetforminCompletedNCT01612741
- Telecoaching of People With Type 2 Diabetes in Primary CareCompletedNCT01612520Not applicable
- A Phase 1 Study to Investigate the Mechanism of Action of IpragliflozinCompletedNCT01611363Phase 1
- The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY)CompletedNCT01610934Phase 2/3
- Lifestyle Modification for Type 2 Diabetes Prevention in Overweight YouthCompletedNCT01610219Not applicable
- Pilot Study of the Effects of Erythritol on Endothelial Function in Patients With Type 2 Diabetes MellitusCompletedNCT01609088Not applicable
- Exercise, Glucose Kinetics, and the Incretin EffectCompletedNCT01607931Not applicable
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetic a Single Day of Dosing With GSK1614235.CompletedNCT01607385Phase 1